Published in Women's Health Weekly, September 15th, 2005
FDA approval triggers the final milestone payment of $4 million under Unigene's exclusive U.S. licensing agreement with Upsher-Smith Laboratories, Inc.
Fortical will be manufactured at Unigene's production facility in Boonton, New Jersey. The final product will be packaged, marketed, and sold in the United States by Upsher-Smith. Unigene will sell the filled product to Upsher-Smith and receive royalties on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.